Report Detail

Pharma & Healthcare Global Panitumumab Market Size, Status and Forecast 2019-2025

  • RnM2976095
  • |
  • 18 February, 2019
  • |
  • Global
  • |
  • 95 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans).
In 2018, the global Panitumumab market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Panitumumab status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Panitumumab development in United States, Europe and China.

The key players covered in this study
Amgen
...

Market segment by Type, the product can be split into
100 mg/5 mL single-dose vials
400 mg/20 mLsingle-dose vials

Market segment by Application, split into
Hospital
Drug store

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Panitumumab status, future forecast, growth opportunity, key market and key players.
To present the Panitumumab development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Panitumumab are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Panitumumab Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 100 mg/5 mL single-dose vials
      • 1.4.3 400 mg/20 mLsingle-dose vials
    • 1.5 Market by Application
      • 1.5.1 Global Panitumumab Market Share by Application (2014-2025)
      • 1.5.2 Hospital
      • 1.5.3 Drug store
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Panitumumab Market Size
    • 2.2 Panitumumab Growth Trends by Regions
      • 2.2.1 Panitumumab Market Size by Regions (2014-2025)
      • 2.2.2 Panitumumab Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Panitumumab Market Size by Manufacturers
      • 3.1.1 Global Panitumumab Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Panitumumab Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Panitumumab Market Concentration Ratio (CR5 and HHI)
    • 3.2 Panitumumab Key Players Head office and Area Served
    • 3.3 Key Players Panitumumab Product/Solution/Service
    • 3.4 Date of Enter into Panitumumab Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Panitumumab Market Size by Type (2014-2019)
    • 4.2 Global Panitumumab Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Panitumumab Market Size (2014-2019)
    • 5.2 Panitumumab Key Players in United States
    • 5.3 United States Panitumumab Market Size by Type
    • 5.4 United States Panitumumab Market Size by Application

    6 Europe

    • 6.1 Europe Panitumumab Market Size (2014-2019)
    • 6.2 Panitumumab Key Players in Europe
    • 6.3 Europe Panitumumab Market Size by Type
    • 6.4 Europe Panitumumab Market Size by Application

    7 China

    • 7.1 China Panitumumab Market Size (2014-2019)
    • 7.2 Panitumumab Key Players in China
    • 7.3 China Panitumumab Market Size by Type
    • 7.4 China Panitumumab Market Size by Application

    8 Japan

    • 8.1 Japan Panitumumab Market Size (2014-2019)
    • 8.2 Panitumumab Key Players in Japan
    • 8.3 Japan Panitumumab Market Size by Type
    • 8.4 Japan Panitumumab Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Panitumumab Market Size (2014-2019)
    • 9.2 Panitumumab Key Players in Southeast Asia
    • 9.3 Southeast Asia Panitumumab Market Size by Type
    • 9.4 Southeast Asia Panitumumab Market Size by Application

    10 India

    • 10.1 India Panitumumab Market Size (2014-2019)
    • 10.2 Panitumumab Key Players in India
    • 10.3 India Panitumumab Market Size by Type
    • 10.4 India Panitumumab Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Panitumumab Market Size (2014-2019)
    • 11.2 Panitumumab Key Players in Central & South America
    • 11.3 Central & South America Panitumumab Market Size by Type
    • 11.4 Central & South America Panitumumab Market Size by Application

    12 International Players Profiles

    • 12.1 Amgen
      • 12.1.1 Amgen Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Panitumumab Introduction
      • 12.1.4 Amgen Revenue in Panitumumab Business (2014-2019)
      • 12.1.5 Amgen Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Summary:
      Get latest Market Research Reports on Panitumumab -2025. Industry analysis & Market Report on Panitumumab -2025 is a syndicated market report, published as Global Panitumumab Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Panitumumab -2025 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,014.70
      4,522.05
      6,029.40
      3,630.90
      5,446.35
      7,261.80
      595,491.00
      893,236.50
      1,190,982.00
      329,160.00
      493,740.00
      658,320.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report